Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 19, Issue 5, 2004, Pages 494-498

  Prasad, Narayan ^a   Gulati, Sanjeev ^a,b   Sharma, Raj Kumar ^a   Singh, Uttam ^a   Ahmed, Muffazal ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Intravenous cyclophosphamide; Nephrotic syndrome; Steroid dependence

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISOLONE; STEROID;

ADOLESCENT; ALOPECIA; AMENORRHEA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFECTION; KAPLAN MEIER METHOD; LEUKOPENIA; MALE; NAUSEA AND VOMITING; NEPHROTIC SYNDROME; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; SURVIVAL ANALYSIS;

EID: 2342644096     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1404-x     Document Type: Article

References (21)

1. Gulati S, Kher V, Sharma R K, Gupta A (1994) Steroid response pattern in Indian children with nephrotic syndrome. Acta Paediatr Scand 83:530-533
2. Barnett HL, Nash MA, Edelmann Jr CM, Bernstein J (1992) Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerular sclerosis. In: Pediatric kidney disease. Little Brown, Boston, pp 1267-1291
3. Takeda A, Ohgushi H, Niimura F, Matsutani H (1998) Long term effects of immunosuppressants in steroid dependent nephrotic syndrome. Pediatr Nephrol 12:746-750
4. Trompeter RS (1986) Minimal change nephrotic syndrome and cyclophosphamide. Arch Dis Child 61:727-729
5. Groot K de, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16:2018-2027
6. Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB (1994) Intravenous pulse cyclophosphamide treatment of lupus nephritis: a prospective five year study. Clin Nephrol 42:71-78
7. Austin HA 3rd, Klippel JH, Balow JE, Riche NG le, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisolone and cytotoxic drugs. N Engl J Med 314:614-619
8. Martin F, Lauwerys B, Lefebvre C, Devogelaer JP, Houssaiu FA (1997) Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 6:254-257
9. Haubitz M, Ehlerding C, Kamino K, Koch KM, Brunckhorst R (1998) Reduced gonadal toxicity after IV cyclophosphamide administration in patients with nonmalignant disease. Clin Nephrol 49:19-23
10. Ehlence R, Gulati S, Kher V, Elhence R, Kumar P, Sharma RK, Gupta A (1994) Intravenous pulse cyclophosphamide - a new regime for steroid resistant minimal change nephrotic syndrome. Pediatr Nephrol 8:1-3
11. Gulati S, Pokhariyal S, Sharma RK, Ehlence R, Kher V, Pandey CM, Gupta A (2001) Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 16:2013-2017
12. Gulati S, Kher V, Ehlence R, Kumar P, Sharma RK, Gupta A (1994) Treatment of nephrotic syndrome. Indian Paediatr 31:165-170
13. Garin EH, Pryor ND, Fennell RS, Richard GA (1998) Pattern of response to prednisolone in idiopathic minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy Am J Dis Child 142:985-988
14. Srivastava RN, Agarwal RK, Chowdhary VP, Moudgil A, Bhuyan UN, Sunderram KL (1987) Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence. Int J Paediatr Nephrol 6:245-250
15. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Treatment of steroid dependent nephrotic syndrome: comparison of 8 weeks with 12 weeks course, Arch Dis Child 62:1102-1106
16. Ueda N, Kuno K, Ito S (1990) Eight and twelve week course of cyclophosphamide in nephrotic syndrome. Arch Dis Child 65:1147-1150
17. Kashtan C, Melvin T, Kim Y (1988) Long term follow up of patients with steroid dependent minimal change nephrotic syndrome. Clin Nephrol 29:79-85
18. Shofet I, Meyerovitch J, Aladjem M, Boichis H (1988) Cyclophosphamide in treatment of minimal change nephrotic syndrome. Eur J Paediatr 147:239-241
19. Broyer M, Meyrier A, Niaudet P, Habib R (1998) Minimal change and focal glomerular sclerosis. In: Davison AM, Cameron JS, Grunfeld JP, Kerr DNS, Ritz E, Winerals CG (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford, pp 493-535
20. Kala UK, Rennert WP, Jacob D, Goestsch S, Verhaart S (1999) Pulse cyclophosphamide for steroid-resistant FSGS. Pediatr Nephrol 13:113-116
21. Jones BF (1993) Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome. Nephron 63:472